62.65
0.95 (1.54%)
前收盘价格 | 61.70 |
收盘价格 | 63.33 |
成交量 | 923,580 |
平均成交量 (3个月) | 1,876,150 |
市值 | 2,102,627,968 |
市盈率 (P/E TTM) | 67.37 |
预期市盈率 (P/E Forward) | 58.14 |
价格/销量 (P/S) | 5.96 |
股市价格/股市净资产 (P/B) | 11.05 |
52周波幅 | |
利润日期 | 24 Feb 2025 - 28 Feb 2025 |
营业毛利率 | 8.14% |
营业利益率 (TTM) | 3.61% |
稀释每股收益 (EPS TTM) | 0.930 |
季度收入增长率 (YOY) | 63.70% |
总债务/股东权益 (D/E MRQ) | 246.83% |
流动比率 (MRQ) | 8.20 |
营业现金流 (OCF TTM) | 37.44 M |
杠杆自由现金流 (LFCF TTM) | -142.59 M |
资产报酬率 (ROA TTM) | 2.84% |
股东权益报酬率 (ROE TTM) | 19.41% |
市场趋势
短期 | 中期 | ||
行业 | Medical Devices (US) | 混合的 | 混合的 |
Medical Devices (全球的) | 混合的 | 混合的 | |
股票 | TransMedics Group, Inc. | 看跌 | 看涨 |
AIStockmoo 评分
分析师共识 | 1.0 |
内部交易活动 | NA |
价格波动 | 4.5 |
技术平均移动指标 | -1.0 |
技术振荡指标 | -2.0 |
平均 | 0.63 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. |
|
部门 | Healthcare |
行业 | Medical Devices |
投资方式 | Small Growth |
内部持股比例 | 3.21% |
机构持股比例 | 113.48% |
52周波幅 | ||
目标价格波幅 | ||
高 | 125.00 (Oppenheimer, 99.52%) | 购买 |
中 | 109.00 (73.98%) | |
低 | 75.00 (JP Morgan, 19.71%) | 保留 |
平均值 | 106.14 (69.42%) | |
总计 | 5 购买, 2 保留 | |
平均价格@调整类型 | 72.29 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
JP Morgan | 17 Dec 2024 | 75.00 (19.71%) | 保留 | 65.71 |
29 Oct 2024 | 116.00 (85.16%) | 购买 | 88.50 | |
Baird | 11 Dec 2024 | 120.00 (91.54%) | 购买 | 67.36 |
29 Oct 2024 | 150.00 (139.43%) | 购买 | 88.50 | |
Piper Sandler | 11 Dec 2024 | 90.00 (43.66%) | 购买 | 67.36 |
20 Nov 2024 | 110.00 (75.58%) | 购买 | 77.20 | |
Oppenheimer | 03 Dec 2024 | 125.00 (99.52%) | 购买 | 71.44 |
29 Oct 2024 | 125.00 (99.52%) | 购买 | 88.50 | |
Needham | 22 Nov 2024 | 109.00 (73.98%) | 保留 | 76.04 |
29 Oct 2024 | 109.00 (73.98%) | 购买 | 88.50 | |
Canaccord Genuity | 20 Nov 2024 | 104.00 (66.00%) | 购买 | 77.20 |
29 Oct 2024 | 109.00 (73.98%) | 购买 | 88.50 | |
TD Cowen | 18 Nov 2024 | 120.00 (91.54%) | 购买 | 80.93 |
显示更多 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合